PTGS2 and nasopharyngeal carcinoma: Our previous studies have demonstrated that COX-2 is present in mitochondria (mito-COX-2) and that suppression of COX-2 translocation to mitochondria inhibits mitochondrial fission, cancer stemness, and apoptosis resistance in nasopharyngeal carcinoma cells [24].